Davita (NYSE:DVA) issued its quarterly earnings results on Tuesday. The company reported $0.92 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.94 by ($0.02), Bloomberg Earnings reports. Davita had a net margin of 3.40% and a return on equity of 13.31%. During the same quarter last year, the company earned $0.98 earnings per share.

Shares of Davita (NYSE DVA) opened at $73.54 on Wednesday. The company has a debt-to-equity ratio of 1.79, a quick ratio of 1.35 and a current ratio of 1.40. Davita has a 52 week low of $52.51 and a 52 week high of $80.71. The company has a market cap of $13,410.00, a PE ratio of 28.18 and a beta of 0.99.

A number of equities research analysts have weighed in on DVA shares. Raymond James Financial raised shares of Davita from an “outperform” rating to a “strong-buy” rating and upped their price target for the company from $65.00 to $84.00 in a report on Thursday, December 7th. Royal Bank of Canada cut their price target on shares of Davita from $64.00 to $60.00 and set a “sector perform” rating for the company in a report on Wednesday, November 8th. Bank of America raised shares of Davita from a “neutral” rating to a “buy” rating and upped their price target for the company from $75.00 to $85.00 in a report on Thursday, January 4th. Robert W. Baird reissued a “hold” rating and issued a $63.00 price target on shares of Davita in a report on Friday, November 10th. Finally, KeyCorp reissued a “hold” rating on shares of Davita in a report on Monday, November 13th. Two analysts have rated the stock with a sell rating, five have given a hold rating, four have issued a buy rating and two have assigned a strong buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $78.60.

In other Davita news, insider James K. Hilger sold 3,572 shares of the company’s stock in a transaction dated Tuesday, January 16th. The shares were sold at an average price of $78.95, for a total transaction of $282,009.40. Following the completion of the sale, the insider now directly owns 33,649 shares of the company’s stock, valued at $2,656,588.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Chairman Kent J. Thiry sold 81,800 shares of the company’s stock in a transaction dated Friday, December 8th. The shares were sold at an average price of $68.04, for a total transaction of $5,565,672.00. The disclosure for this sale can be found here. Insiders have sold 121,509 shares of company stock valued at $8,310,388 over the last ninety days. Insiders own 2.00% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Davita (DVA) Announces Earnings Results” was originally reported by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are accessing this news story on another website, it was copied illegally and reposted in violation of United States and international trademark & copyright law. The original version of this news story can be read at https://theolympiareport.com/2018/02/13/davita-dva-issues-earnings-results-hits-expectations.html.

About Davita

DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.

Earnings History for Davita (NYSE:DVA)

Receive News & Ratings for Davita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davita and related companies with MarketBeat.com's FREE daily email newsletter.